Search Results

There are 17666 results for: content related to: Frequent overexpression of ErbB – receptor family members in brain metastases of non-small cell lung cancer patients

  1. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC1 signalling in breast cancer cell migration and dissemination

    The Journal of Pathology

    Volume 227, Issue 2, June 2012, Pages: 234–244, Lydia M Balz, Kai Bartkowiak, Antje Andreas, Klaus Pantel, Bernd Niggemann, Kurt S Zänker, Burkhard H Brandt and Thomas Dittmar

    Version of Record online : 21 MAR 2012, DOI: 10.1002/path.3991

    Corrected by:

    Erratum: Erratum

    Vol. 230, Issue 1, e1, Version of Record online: 10 APR 2013

  2. Meta-analysis reveals no significant correlation between breast cancer survival and ErbB3 expression


    Volume 123, Issue 5, May 2015, Pages: 383–393, Hyun Jung Kim, Aeree Kim, HyeongSik Ahn, Il Min Ahn, Jinhyuk Choi and Hyeyoon Chang

    Version of Record online : 25 APR 2015, DOI: 10.1111/apm.12371

  3. You have free access to this content
    Calpain4 is required for activation of HER2 in breast cancer cells exposed to trastuzumab and its suppression decreases survival and enhances response

    International Journal of Cancer

    Volume 131, Issue 10, 15 November 2012, Pages: 2420–2432, Sucheta Kulkarni, Leya Saju, Carol Farver and Raymond Tubbs

    Version of Record online : 28 MAR 2012, DOI: 10.1002/ijc.27510

  4. Pan-HER – an antibody mixture targeting EGFR, HER2, and HER3 abrogates preformed and ligand-induced EGFR homo- and heterodimers

    International Journal of Cancer

    Accepted manuscript online: 25 JUN 2016, Sofie Ellebæk, Susanne Brix, Michael Grandal, Johan Lantto, Ivan D. Horak, Michael Kragh and Thomas Tuxen Poulsen

    DOI: 10.1002/ijc.30242

  5. Increased tumor cell expression of Axl is a marker of aggressive features in breast cancer among African women


    Volume 123, Issue 8, August 2015, Pages: 688–696, Lavina Ahmed, Hawa Nalwoga, Jarle B. Arnes, Henry Wabinga, David R. Micklem and Lars A. Akslen

    Version of Record online : 25 MAY 2015, DOI: 10.1111/apm.12403

  6. You have free access to this content
    EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer

    International Journal of Cancer

    Volume 135, Issue 7, 01 October 2014, Pages: 1517–1530, Christiane Daniela Fichter, Sylvia Timme, Julia Alexandra Braun, Verena Gudernatsch, Anja Schöpflin, Lioudmilla Bogatyreva, Helene Geddert, Gerhard Faller, David Klimstra, Laura Tang, Dieter Hauschke, Martin Werner and Silke Lassmann

    Version of Record online : 2 APR 2014, DOI: 10.1002/ijc.28771

  7. Antibody targeting of HER2/HER3 signaling overcomes heregulin-induced resistance to PI3K inhibition in prostate cancer

    International Journal of Cancer

    Volume 137, Issue 2, 15 July 2015, Pages: 267–277, Jayakumar S. Poovassery, Jeffrey C. Kang, Dongyoung Kim, Raimund J. Ober and E. Sally Ward

    Version of Record online : 19 DEC 2014, DOI: 10.1002/ijc.29378

  8. Essential role of Her3 in two signaling transduction patterns: Her2/Her3 and MET/Her3 in proliferation of human gastric cancer

    Molecular Carcinogenesis

    Volume 54, Issue 12, December 2015, Pages: 1700–1709, Chen Yun, Li Gang, Gu Rongmin, Wen Xu, Ming Xuezhi and Chen Huanqiu

    Version of Record online : 14 NOV 2014, DOI: 10.1002/mc.22241

  9. You have full text access to this OnlineOpen article
    ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells

    Cancer Medicine

    Volume 1, Issue 1, August 2012, Pages: 28–38, Byung-Kwon Choi, Xuejun Fan, Hui Deng, Ningyan Zhang and Zhiqiang An

    Version of Record online : 15 JUL 2012, DOI: 10.1002/cam4.10

  10. Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2-Positive Breast Cancer

    Chemical Biology & Drug Design

    Volume 85, Issue 6, June 2015, Pages: 702–714, Shanthi Kanthala, Sashikanth Banappagari, Ameya Gokhale, Yong-Yu Liu, Gu Xin, Yunfeng Zhao and Seetharama Jois

    Version of Record online : 6 NOV 2014, DOI: 10.1111/cbdd.12453

  11. You have free access to this content
    Anti-HER-3 MAbs inhibit HER-3-mediated signaling in breast cancer cell lines resistant to anti-HER-2 antibodies

    International Journal of Cancer

    Volume 115, Issue 4, 1 July 2005, Pages: 519–527, Edward Htun van der Horst, Marta Murgia, Martin Treder and Axel Ullrich

    Version of Record online : 9 FEB 2005, DOI: 10.1002/ijc.20867

  12. You have full text access to this OnlineOpen article
    Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma

    Journal of Oral Pathology & Medicine

    Volume 44, Issue 9, October 2015, Pages: 734–745, Barbara Cortelazzi, Paolo Verderio, Chiara Maura Ciniselli, Sara Pizzamiglio, Paolo Bossi, Annunziata Gloghini, Ambra V. Gualeni, Chiara C. Volpi, Laura Locati, Marco A. Pierotti, Lisa Licitra, Silvana Pilotti and Federica Perrone

    Version of Record online : 14 DEC 2014, DOI: 10.1111/jop.12301

  13. Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor – Apocrine epithelium and carcinomas emerging as uniformly positive


    Volume 122, Issue 9, September 2014, Pages: 824–831, Bence Kővári, Orsolya Rusz, Andrew V. Schally, Zsuzsanna Kahán and Gábor Cserni

    Version of Record online : 31 JAN 2014, DOI: 10.1111/apm.12224

  14. You have full text access to this Open Access content
    Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer

    Cancer Science

    Volume 102, Issue 1, January 2011, Pages: 1–8, Toru Mukohara

    Version of Record online : 6 SEP 2010, DOI: 10.1111/j.1349-7006.2010.01711.x

  15. Mutational and expressional analysis of ERBB3 gene in common solid cancers


    Volume 122, Issue 12, December 2014, Pages: 1207–1212, Mi Ryoung Choi, Chang Hyeok An, Yeun Jun Chung, Youn Jin Choi, Nam Jin Yoo and Sug Hyung Lee

    Version of Record online : 7 JUN 2014, DOI: 10.1111/apm.12286

  16. Phosphorylation of STAT3 correlates with HER2 status, but not with survival in pancreatic ductal adenocarcinoma


    Volume 122, Issue 6, June 2014, Pages: 476–481, Oskar Koperek, Klaus Aumayr, Martin Schindl, Gregor Werba, Afschin Soleiman, Sebastian Schoppmann, Klaus Sahora and Peter Birner

    Version of Record online : 29 OCT 2013, DOI: 10.1111/apm.12194

  17. Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin-binding domain allows for affinity purification and in vivo half-life extension

    Biotechnology Journal

    Volume 9, Issue 9, September 2014, Pages: 1215–1222, Magdalena Malm, Tarek Bass, Lindvi Gudmundsdotter, Martin Lord, Fredrik Y. Frejd, Stefan Ståhl and John Löfblom

    Version of Record online : 23 APR 2014, DOI: 10.1002/biot.201400009

  18. Forskolin increases neuregulin receptors in human Schwann cells without increasing receptor mRNA


    Volume 49, Issue 1, 1 January 2005, Pages: 24–35, Nevis L. Fregien, Linda A. White, Mary Bartlett Bunge and Patrick M. Wood

    Version of Record online : 27 JUL 2004, DOI: 10.1002/glia.20091

  19. Targeted therapy in gastric cancer


    Volume 123, Issue 5, May 2015, Pages: 365–372, Alexandra Thiel and Ari Ristimäki

    Version of Record online : 23 FEB 2015, DOI: 10.1111/apm.12359

  20. Expression patterns of stromal MMP-2 and tumoural MMP-2 and -9 are significant prognostic factors in invasive ductal carcinoma of the breast


    Volume 122, Issue 12, December 2014, Pages: 1196–1206, Kyueng-Whan Min, Dong-Hoon Kim, Sung-Im Do, Kyungeun Kim, Hyun Joo Lee, Seoung Wan Chae, Jin Hee Sohn, Jung-Soo Pyo, Young-Ha Oh, Wan-Seop Kim, So-Young Lee, Sukjoong Oh, Seon Hyeong Choi, Yong Lai Park and Chan Heun Park

    Version of Record online : 7 JUN 2014, DOI: 10.1111/apm.12285